文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

OPTN/SRTR 2021 年度数据报告:血管化复合异体移植物。

OPTN/SRTR 2021 Annual Data Report: Vascularized Composite Allograft.

机构信息

Department of Surgery, Duke University, Durham, NC.

Baylor University Medical Center, Dallas, TX.

出版信息

Am J Transplant. 2023 Feb;23(2 Suppl 1):S523-S545. doi: 10.1016/j.ajt.2023.02.012.


DOI:10.1016/j.ajt.2023.02.012
PMID:37132342
Abstract

Year 2020 marked the first OPTN/SRTR Annual Data Report that included a chapter on vascularized composite allograft (VCA), which encompassed reviews of data collected between 2014 (when VCA was included in the Final Rule) and 2020. The present Annual Data Report shows that the number of VCA recipients in the United States continues to be small and trended downward in 2021. While data continue to be limited by sample size, trends continue to show a predominance in White, young/middle-aged, male recipients. Similar to the 2020 report, eight uterus and one non-uterus VCA graft failures were reported from 2014 through 2021. Critical to advancement of VCA transplantation will be the standardization of definitions, protocols, and outcome measures for the different VCA types. Like intestinal transplants, it is likely that VCA transplants will be concentrated and performed at referral transplant centers.

摘要

2020 年标志着 OPTN/SRTR 首次发布年度数据报告,其中包含一章专门介绍血管化复合组织移植物(VCA),涵盖了 2014 年(VCA 被纳入最终规定)至 2020 年期间收集的数据审查。本年年报显示,美国接受 VCA 的人数仍然较少,并且在 2021 年呈下降趋势。虽然数据仍然受到样本量的限制,但趋势继续显示白人、年轻/中年、男性受者占主导地位。与 2020 年的报告类似,从 2014 年到 2021 年,报告了 8 例子宫和 1 例非子宫 VCA 移植物失败。推进 VCA 移植的关键将是为不同的 VCA 类型制定定义、方案和结果测量的标准化。与肠移植一样,VCA 移植可能集中在转诊移植中心进行。

相似文献

[1]
OPTN/SRTR 2021 Annual Data Report: Vascularized Composite Allograft.

Am J Transplant. 2023-2

[2]
OPTN/SRTR 2022 Annual Data Report: Vascularized Composite Allograft.

Am J Transplant. 2024-2

[3]
OPTN/SRTR 2020 Annual Data Report: VCA.

Am J Transplant. 2022-3

[4]
OPTN Vascularized Composite Allograft Waiting List: Current Status and Trends in the United States.

Transplantation. 2018-11

[5]
Vascularized composite allotransplantation in the United States: A retrospective analysis of the Organ Procurement and Transplantation Network data after 5 years of the Final Rule.

Am J Transplant. 2021-1

[6]
Vascularized composite allotransplantation in the United States: A descriptive analysis of the Organ Procurement and Transplantation Network Data.

Am J Transplant. 2018-9-17

[7]
The landscape of vascularized composite allograft donation in the United States.

Curr Opin Organ Transplant. 2019-12

[8]
A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.

Transpl Int. 2014-9

[9]
Public education materials about Vascular Composite Allotransplantation and donation in the United States: Current scope and limitations.

Clin Transplant. 2020-11

[10]
Maximizing donors' gifts: A comparison of actual and expected solid organ yield among VCA donors.

Am J Transplant. 2021-3

引用本文的文献

[1]
Multi-Center Outcome Analysis of 16 Face Transplantations - A Retrospective OPTN Study.

Transpl Int. 2025-1-29

[2]
Emerging strategies for tissue engineering in vascularized composite allotransplantation: A review.

J Tissue Eng. 2024-5-30

[3]
Partial heart transplantation: a new option for paediatric heart valve replacement.

Nat Rev Cardiol. 2024-5

[4]
Partial heart transplantation: Growing heart valve implants for children.

Artif Organs. 2024-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索